Tissue Genesis

Tissue Genesis begins trials for PVD using ASCs

Wednesday, April 20, 2011

Tissue Genesis, a company focused on adult stem cell and regenerative medicine, has begun clinical trials for peripheral vascular disease (PVD) with adipose-derived adult stem cell-coated vascular grafts at the University of Louisville hospital.  Tissue Genesis is the first to initiate a FDA-approved trial using the patient’s own adipose-derived adult stem cells (ASCs) prepared at the point-of-care. 

[Read More]